- Home
- RARE vs ZIM Comparison
RARE vs ZIM Comparison
Compare RARE & ZIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RARE | ZIM |
|---|---|---|
| Founded | 2010 | 1945 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.6B |
| IPO Year | 2014 | 2021 |
Fundamental Metrics
Financial Performance| Metric | RARE | ZIM |
|---|---|---|
| Price | $23.86 | $20.20 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 19 | 5 |
| Target Price | ★ $73.11 | $15.04 |
| AVG Volume (30 Days) | 2.7M | ★ 3.3M |
| Earning Date | 02-13-2026 | 03-11-2026 |
| Dividend Yield | N/A | ★ 19.88% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 8.31 |
| Revenue | $630,598,000.00 | ★ $7,587,100,000.00 |
| Revenue This Year | $20.17 | N/A |
| Revenue Next Year | $19.10 | N/A |
| P/E Ratio | ★ N/A | $2.59 |
| Revenue Growth | ★ 20.63 | 1.63 |
| 52 Week Low | $18.41 | $11.04 |
| 52 Week High | $46.50 | $24.47 |
Technical Indicators
Market Signals| Indicator | RARE | ZIM |
|---|---|---|
| Relative Strength Index (RSI) | 41.45 | 40.69 |
| Support Level | $23.26 | $22.51 |
| Resistance Level | $25.82 | $22.61 |
| Average True Range (ATR) | 1.02 | 0.97 |
| MACD | 0.43 | -0.32 |
| Stochastic Oscillator | 48.69 | 3.64 |
Price Performance
Historical ComparisonAbout RARE Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. It identifies, acquires, develops, and commercializes novel products for the treatment of serious rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. The company's medicine portfolio includes Crysvita, Dojolvi and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 1 year of age and older. Mepsevii is indicated in pediatric and adult patients for the treatment of Mucopolysaccharidosis VII.
About ZIM ZIM Integrated Shipping Services Ltd.
ZIM Integrated Shipping Services Ltd is an asset-light container liner shipping company. It offers tailored services, including land transportation and logistical services, specialized shipping solutions, including the transportation of out-of-gauge cargo, refrigerated cargo, and dangerous and hazardous cargo. Its services include Cargo Services, Digital Services, Schedules, and Shipping Trades and Lines. Geographically, it derives a majority of its revenue from the Pacific trade region.